Reliq Net Income from 2010 to 2026
| RHT Stock | CAD 0.22 0.00 0.00% |
Net Loss | First Reported 2006-03-31 | Previous Quarter -71.3 K | Current Value 731 K | Quarterly Volatility 1.5 M |
Check Reliq Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reliq Health's main balance sheet or income statement drivers, such as Total Revenue of 10.3 M, Gross Profit of 6.4 M or Other Operating Expenses of 20.3 M, as well as many indicators such as Price To Sales Ratio of 279, Dividend Yield of 0.0 or PTB Ratio of 27.06. Reliq financial statements analysis is a perfect complement when working with Reliq Health Valuation or Volatility modules.
Reliq | Net Income |
The evolution of Net Income for Reliq Health Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Reliq Health compares to historical norms and industry peers.
Latest Reliq Health's Net Income Growth Pattern
Below is the plot of the Net Income of Reliq Health Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Reliq Health Technologies financial statement analysis. It represents the amount of money remaining after all of Reliq Health Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Reliq Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reliq Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.17 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Reliq Net Income Regression Statistics
| Arithmetic Mean | (6,378,610) | |
| Coefficient Of Variation | (68.72) | |
| Mean Deviation | 3,695,638 | |
| Median | (7,241,593) | |
| Standard Deviation | 4,383,498 | |
| Sample Variance | 19.2T | |
| Range | 13.8M | |
| R-Value | (0.62) | |
| Mean Square Error | 12.7T | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | (536,892) | |
| Total Sum of Squares | 307.4T |
Reliq Net Income History
About Reliq Health Financial Statements
Reliq Health investors use historical fundamental indicators, such as Reliq Health's Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Reliq Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -7.4 M | -7 M | |
| Net Loss | -7.4 M | -7.7 M | |
| Net Loss | -7.4 M | -7.7 M | |
| Net Loss | (0.42) | (0.44) | |
| Net Income Per E B T | 1.04 | 1.02 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Reliq Stock Analysis
When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.